Comparable stake leader
BlackRock Portfolio Management LLC
SEC ownership of Verona Pharma plc
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001657312.
Disclosed value leader
Growth Equity Opportunities Fund IV, LLC
Comparable rows
5/24
Latest evidence
07 Oct 2025
- Parsed ownership sources
-
13D/G and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
BlackRock Portfolio Management LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
5 of 24
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
BlackRock Portfolio Management LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
07 Oct 2025
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001657312
- Issuer location
- London, United Kingdom
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Verona Pharma plc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock Portfolio Manag...
Disclosed value leader
Growth Equity Opportuniti...
Comparable rows
5/24
Latest evidence
07 Oct 2025
13D/G
3/4/5
Lead comparable stake: 6%
19 rows are not safely comparable across share classes.
13D/G row: BlackRock Portfolio Management LLC
Showing 1-8 of 24 holder rows.
Quick read
BlackRock Portfolio Management LLC leads the comparable SEC ownership view at 6%.
5 of 24 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock Portfolio Management LLC's linked filing trail.
Comparable ownership
Top 5
BlackRock Portfolio Management LLC
6%
Growth Equity Opportunities Fund ...
5%
MAVERICK CAPITAL LTD
3.8%
Janus Henderson Group Ltd.
1.2%
RA CAPITAL MANAGEMENT, L.P.
0.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 24 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock Portfolio Management LLC |
13D/G
|
6%
|
—
27,645,624 shares
|
$0 | 30 Sep 2025 |
| Growth Equity Opportunities Fund IV, LLC |
13D/G
Scott D. Sandell
|
5%
|
$2,139,209,824
32,679,649 shares
|
$0 | 16 Jan 2025 |
| MAVERICK CAPITAL LTD |
13D/G
|
3.8%
|
$1,638,341,259
25,028,128 shares
|
$0 | 31 Dec 2024 |
| Janus Henderson Group Ltd. |
13D/G
JANUS HENDERSON GROUP PLC
|
1.2%
|
$107,837,284
1,010,564 shares
|
-$546,765,073 | 30 Sep 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
0.7%
|
$62,198,806
593,670 shares
|
-$567,585,398 | 30 Jun 2025 |
| Access Industries Holdings LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$1,118,232,960
55,911,648 shares
|
— | 15 Aug 2022 |
| ORBIMED ADVISORS LLC |
3/4/5
Director
|
—
class O/S missing
|
$75,555,560
3,777,778 shares
|
— | 11 May 2023 |
| Rishi Gupta |
3/4/5
Director
|
—
class O/S missing
|
$75,555,560
3,777,778 shares
|
— | 11 May 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 14 Sep 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-19 of 19 reporting-owner rows connected to Verona Pharma plc. Open a relationship link for the CIK-to-CIK filing trail.
Rows
19
Largest Forms 3/4/5 holder
Access Industries Holdings LLC
Net 12M change
$0
Latest report
07 Oct 2025
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Access Industries Holdings LLC | 10%+ Owner | $1,118,232,960 | Mixed | 15 Aug 2022 | ||
| Rishi Gupta | Director | $75,555,560 | Filing P/S | 11 May 2023 | ||
| ORBIMED ADVISORS LLC | Director | $75,555,560 | Filing P/S | 11 May 2023 | ||
| Claire Poll | General Counsel | $56,008,140 | Mixed | 01 Feb 2024 | ||
| Martin Edwards | Director | $0 | Mixed | 07 Oct 2025 | ||
| Mark W. Hahn | Chief Financial Officer | $0 | Mixed | 07 Oct 2025 | ||
| Christina Ackermann | Director | $0 | Mixed | 07 Oct 2025 | ||
| James Aloysius Brady | Director | $0 | Mixed | 07 Oct 2025 | ||
| Anders Ullman | Director | $0 | Mixed | 07 Oct 2025 | ||
| Kathleen A. Rickard | Chief Medical Officer | $0 | Mixed | 07 Oct 2025 | ||
| Mahendra Shah | Director | $0 | Mixed | 07 Oct 2025 | ||
| Kenneth Cunningham | Director | $0 | Mixed | 07 Oct 2025 | ||
| David Zaccardelli | President and CEO, Director | $0 | Mixed | 07 Oct 2025 | ||
| Michael Austwick | Director | $0 | Mixed | 07 Oct 2025 | ||
| David R. Ebsworth | Director | $0 | Mixed | 07 Oct 2025 | ||
| Andrew Fisher | General Counsel | $0 | Mixed | 07 Oct 2025 | ||
| Lisa Deschamps | Director | $0 | Mixed | 07 Oct 2025 | ||
| Vikas Sinha | Director | $0 | Mixed | 07 Oct 2025 | ||
| Andrew Sinclair | Director | Mixed | 09 Aug 2021 |
Recent insider transactions for Verona Pharma plc
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Andrew Fisher | VRNA | Ordinary Shares | Options Exercise | 931,984 | 931,984 | 07 Oct 2025 | Direct | |||
| Andrew Fisher | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -1,349,887 | 0 | 07 Oct 2025 | Direct | ||
| Andrew Fisher | VRNA | Share Options (Right to Buy) | Disposed to Issuer | -100% | -2,240,000 | 0 | 07 Oct 2025 | Direct | ||
| Andrew Fisher | VRNA | Restricted Share Unit | Award | 618,760 | 618,760 | 07 Oct 2025 | Direct | |||
| Andrew Fisher | VRNA | Restricted Share Unit | Options Exercise | -100% | -931,984 | 0 | 07 Oct 2025 | Direct | ||
| David Zaccardelli | VRNA | Ordinary Shares | Options Exercise | 3,285,280 | 3,285,280 | 07 Oct 2025 | Direct | |||
| David Zaccardelli | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -15,461,424 | 0 | 07 Oct 2025 | Direct | ||
| David Zaccardelli | VRNA | Restricted Share Unit | Award | 1,649,952 | 1,649,952 | 07 Oct 2025 | Direct | |||
| David Zaccardelli | VRNA | Restricted Share Unit | Options Exercise | -100% | -3,285,280 | 0 | 07 Oct 2025 | Direct | ||
| Kathleen A. Rickard | VRNA | Ordinary Shares | Options Exercise | 1,131,984 | 1,131,984 | 07 Oct 2025 | Direct | |||
| Kathleen A. Rickard | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -3,564,852 | 0 | 07 Oct 2025 | Direct | ||
| Kathleen A. Rickard | VRNA | Share Options (Right to Buy) | Disposed to Issuer | -100% | -660,000 | 0 | 07 Oct 2025 | Direct | ||
| Kathleen A. Rickard | VRNA | Restricted Share Unit | Award | 618,760 | 618,760 | 07 Oct 2025 | Direct | |||
| Kathleen A. Rickard | VRNA | Restricted Share Unit | Options Exercise | -100% | -1,131,984 | 0 | 07 Oct 2025 | Direct | ||
| Mark W. Hahn | VRNA | Ordinary Shares | Options Exercise | 3,285,280 | 3,285,280 | 07 Oct 2025 | Direct | |||
| Mark W. Hahn | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -14,550,248 | 0 | 07 Oct 2025 | Direct | ||
| Mark W. Hahn | VRNA | Restricted Share Unit | Award | 1,649,952 | 1,649,952 | 07 Oct 2025 | Direct | |||
| Mark W. Hahn | VRNA | Restricted Share Unit | Options Exercise | -100% | -3,285,280 | 0 | 07 Oct 2025 | Direct | ||
| Michael Austwick | VRNA | Ordinary Shares | Options Exercise | 72,000 | 72,000 | 07 Oct 2025 | Direct | |||
| Michael Austwick | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -84,712 | 0 | 07 Oct 2025 | Direct | ||
| Michael Austwick | VRNA | Share Options (Right to Buy) | Disposed to Issuer | -100% | -144,000 | 0 | 07 Oct 2025 | Direct | ||
| Michael Austwick | VRNA | Restricted Share Unit | Options Exercise | -100% | -72,000 | 0 | 07 Oct 2025 | Direct | ||
| Anders Ullman | VRNA | Ordinary Shares | Options Exercise | 72,000 | 72,000 | 07 Oct 2025 | Direct | |||
| Anders Ullman | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -430,856 | 0 | 07 Oct 2025 | Direct | ||
| Anders Ullman | VRNA | Share Options (Right to Buy) | Disposed to Issuer | -100% | -600,000 | 0 | 07 Oct 2025 | Direct | ||
| Anders Ullman | VRNA | Restricted Share Unit | Options Exercise | -100% | -72,000 | 0 | 07 Oct 2025 | Direct | ||
| Mahendra Shah | VRNA | Ordinary Shares | Options Exercise | 72,000 | 72,000 | 07 Oct 2025 | Direct | |||
| Mahendra Shah | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -165,472 | 0 | 07 Oct 2025 | Direct | ||
| Mahendra Shah | VRNA | Share Options (Right to Buy) | Disposed to Issuer | -100% | -600,000 | 0 | 07 Oct 2025 | Direct | ||
| Mahendra Shah | VRNA | Restricted Share Unit | Options Exercise | -100% | -72,000 | 0 | 07 Oct 2025 | Direct | ||
| Vikas Sinha | VRNA | Ordinary Shares | Options Exercise | 72,000 | 72,000 | 07 Oct 2025 | Direct | |||
| Vikas Sinha | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -166,112 | 0 | 07 Oct 2025 | Direct | ||
| Vikas Sinha | VRNA | Share Options (Right to Buy) | Disposed to Issuer | -100% | -400,384 | 0 | 07 Oct 2025 | Direct | ||
| Vikas Sinha | VRNA | Restricted Share Unit | Options Exercise | -100% | -72,000 | 0 | 07 Oct 2025 | Direct | ||
| Lisa Deschamps | VRNA | Ordinary Shares | Options Exercise | 72,000 | 72,000 | 07 Oct 2025 | Direct | |||
| Lisa Deschamps | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -156,856 | 0 | 07 Oct 2025 | Direct | ||
| Lisa Deschamps | VRNA | Share Options (Right to Buy) | Disposed to Issuer | -100% | -600,000 | 0 | 07 Oct 2025 | Direct | ||
| Lisa Deschamps | VRNA | Restricted Share Unit | Options Exercise | -100% | -72,000 | 0 | 07 Oct 2025 | Direct | ||
| David R. Ebsworth | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -617,600 | 0 | 07 Oct 2025 | By Ebsworth GmbH | ||
| David R. Ebsworth | VRNA | Ordinary Shares | Options Exercise | 72,000 | 72,000 | 07 Oct 2025 | Direct | |||
| David R. Ebsworth | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -952,499 | 0 | 07 Oct 2025 | Direct | ||
| David R. Ebsworth | VRNA | Restricted Share Unit | Options Exercise | -100% | -72,000 | 0 | 07 Oct 2025 | Direct | ||
| Martin Edwards | VRNA | Ordinary Shares | Options Exercise | 72,000 | 72,000 | 07 Oct 2025 | Direct | |||
| Martin Edwards | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -229,992 | 0 | 07 Oct 2025 | Direct | ||
| Martin Edwards | VRNA | Share Options (Right to Buy) | Disposed to Issuer | -100% | -600,000 | 0 | 07 Oct 2025 | Direct | ||
| Martin Edwards | VRNA | Restricted Share Unit | Options Exercise | -100% | -72,000 | 0 | 07 Oct 2025 | Direct | ||
| James Aloysius Brady | VRNA | Ordinary Shares | Options Exercise | 72,000 | 72,000 | 07 Oct 2025 | Direct | |||
| James Aloysius Brady | VRNA | Ordinary Shares | Disposed to Issuer | -100% | -95,176 | 0 | 07 Oct 2025 | Direct | ||
| James Aloysius Brady | VRNA | Share Options (Right to Buy) | Disposed to Issuer | -100% | -624,000 | 0 | 07 Oct 2025 | Direct | ||
| James Aloysius Brady | VRNA | Restricted Share Unit | Options Exercise | -100% | -72,000 | 0 | 07 Oct 2025 | Direct |
* marks a reported price that did not pass the local price check.